This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Siegfried Goldman
Introduction
Siegfried Goldman is a notable inventor based in Wuppertal, Germany, recognized for his significant contributions to the field of medicinal chemistry. With an impressive patent portfolio that includes innovative compounds, Goldman has made strides in the development of pharmaceutical agents aimed at treating various health conditions.
Latest Patents
Goldman's most prominent patent, which he holds, pertains to "Condensed quinolyl-dihydropyridines." This invention revolves around novel, condensed 4-quinolyl-dihydropyridines, characterized by a specific general formula. These compounds are highlighted for their utility in medicaments, particularly in developing therapies for angiocardiopathies. The processes defined for their preparation further showcase the innovative pathways that Goldman has explored within the pharmaceutical realm.
Career Highlights
Siegfried Goldman is associated with Bayer Aktiengesellschaft, a leading global enterprise in pharmaceuticals and life sciences. His work at Bayer has positioned him at the forefront of research and development in drug formulation, allowing him to contribute valuable insights and inventions to the industry. His trademark focus on complex chemical syntheses has enriched Bayer’s product lineup with cutting-edge therapeutic options.
Collaborations
Throughout his career, Goldman has collaborated with esteemed colleagues, including Jurgen Stoltefuss and Alexander Straub. These partnerships have fostered a creative environment where innovative ideas and solutions can thrive, ultimately leading to refined research outcomes and enhanced invention processes.
Conclusion
Siegfried Goldman stands out as a prominent figure in the realm of medicinal inventions, with his research contributing substantially to advancements in treating heart-related diseases. His patented work not only exemplifies the spirit of innovation but also underlines the importance of collaborative efforts in the scientific community to push the boundaries of what is possible in pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile